Article info

Download PDFPDF
Letter
Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues
  1. Correspondence to Dr David Y Graham, Department of Medicine, Baylor College of Medicine and Michael E DeBakey Veterans Affairs Medical Center, RM 3A-318B (111D), 2002 Holcombe Boulevard, Houston, TX 77030, USA; dgraham{at}bcm.edu
View Full Text

Citation

Graham DY
Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues

Publication history

  • Received March 4, 2016
  • Revised March 14, 2016
  • Accepted March 21, 2016
  • First published April 7, 2016.
Online issue publication 
January 06, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.